David Gold is an associate in Hughes Hubbard & Reed's Corporate department. His experience includes working on transactions in media, finance and private equity, among other industries.
Representation of India-based Cipla Ltd. in its $550 million acquisition of InvaGen Pharmaceuticals Inc. and its acquisition of Exelan Pharmaceuticals Inc.
Representation of The Madison Square Garden Co. in its purchase of a controlling interest in the production company behind the popular music festival Boston Calling
Representation of Merck in its $9.5 billion acquisition of Cubist Pharmaceuticals
Representation of Merck in its $3.85 billion acquisition of Idenix Pharmaceuticals
Representation of Rockwood Holdings Inc. in the sale of its titanium dioxide and performance additives businesses for $1.1 billion to Huntsman Corp.
Representation of The Madison Square Garden Co. in its acquisition of a 50 percent stake in Tribeca Enterprises, the company that owns and operates the acclaimed Tribeca Film Festival and other businesses
Representation of Amur Finance Co. Inc. and affiliates in a number of debt and equity financings related to the purchase and lease of fixed-wing and rotor aircraft